6.50% p.a. Early Redemption Kick-In GOAL

Underlying: Amgen / Gilead / Novartis / Roche SSPA/EUSIPA Product Type: Barrier Reverse Convertibles (1230, Auto-Callable) Valor: 35475443 / ISIN: CH0354754431

Last update 18.01.2019
  • Bid

    99.65 %
    Volume: 100'000

  • Ask

    100.60 %
    Volume: 100'000

Strike100.00%
Early Redemption Level100.00%
CurrencyCHF
IssuerUBS AG, London Branch
Settlementcash
Fixing date15.02.2017
Expiry15.02.2019
Trading placeSIX SP Exchange
Barrier49.00%
Barrier touchedNo
Sideways return-- / --
Accrued interest2)1.05%
Underlying price1)
Amgen
Gilead
Novartis
Roche

203.88 USD
69.18 USD
88.80 CHF
258.40 CHF
Display
  • Product chart

Barrier monitor

NameRoche
Price1)258.40 CHF
Distance to barrier
54.20%
Barrier absolute118.34 CHF
 
NameGilead
Price1)69.18 USD
Distance to barrier
50.56%
Barrier absolute34.20 USD
Worst Performer
NameAmgen
Price1)203.88 USD
Distance to barrier
58.71%
Barrier absolute84.18 USD
 
NameNovartis
Price1)88.80 CHF
Distance to barrier
58.18%
Barrier absolute37.14 CHF
 
1) Prices are 15 Min. delayed 2) Indicative